Breaks total IgG down into its four subclasses from a single blood sample, giving more detail than a total IgG figure alone. Suited to anyone who needs subclass-level detail rather than an overall IgG count.
1 biomarker as listed by Blue Horizon Medicals.
This test measures the four subclasses of immunoglobulin G (IgG) rather than a single total IgG figure. Breaking the total down into subclasses can show more detail than a total IgG count alone, which is why this profile is offered as a standalone test.
Against the 79 similarly sized immunity tests we track, its single combined biomarker entry places it in the 36th percentile for clinical depth, and its £144.25 price is around 12% above the £129.00 median for that group. Collection is by venous blood draw, at a clinic or via a home nurse visit, and results take around 10 days, longer than most other tests in this comparison.
The overall score is held back mainly by the long turnaround and a below-average clinical depth score for a single biomarker profile, alongside a value-for-money score that reflects the above-median price. Results and follow-up score reasonably because a doctor reviews the results. Blue Horizon Medicals holds a 4.2 Trustpilot rating from 395 reviews, uses UKAS ISO 15189 partner labs, and has traded since 2009.
This suits anyone who specifically needs their IgG broken down into its four subclasses, rather than a single total IgG figure or a wider immunity panel.
Because results take around 10 days and the price sits above the median for similarly sized immunity tests we track, it is worth confirming this specific subclass breakdown is what you need before ordering, rather than a faster or cheaper general immunity or immunoglobulin test.
This is a blood test collected by venous draw, either at a clinic or through a nurse home visit; there is no at-home finger-prick option. Results take around 10 days, and a doctor reviews them before you receive them.
This test breaks total IgG into its four subclasses for £144.25, with a doctor reviewing the results in around 10 days. It costs about 12% more than the £129.00 median for the 79 similarly sized immunity tests we track, and its turnaround is one of the slower ones in this comparison. It suits people who specifically need subclass-level detail rather than a broader immunity panel.
The listing publishes a short description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
1 biomarkers, placing it in the 36th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 10 days, slower than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£144.25 against a median of £129.00 for the 79 similarly sized immunity tests we track (+12%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
